2Lennert K, Feller AC. The diagnosis of lymphoma. In: Lennert K, Feller AC, eds. Histopathology of non-Hodgkin's lymphomas. 2nd ed. Berlin: Springer-Verlag, 1992: 1-6.
3Feller AC, -Diebold-J, Histopathology of nodal and extranodal non-Hodgkin's lymphomas, based on the WHO classification. 3rd ed. Berlin: Springer, 2004: 409-414.
4Jaffe ES, Harris NL Stein H, et al. World Health Orgainization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tis sues. Lyon: IARC Press, 2001:121 - 124.
2Broyde A, Boycov O, Strenov Y, et al. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma[ J]. Am J Hematol,2009,84 : 338-343.
3Hofman MS, Hicks R3. Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma [ J ]. Leuk Lymphoma,2010,51 : 183-185.
4Watanabe R, Tomita N, Takeuchi K, et al. SUVmax in FDG- PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma [ J ]. Leuk Lymphoma, 2010, 51 : 279-283.
5Papajik T, Myslivecek M, Sedova Z, et al. Standardised uptake value of is F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma [ J ]. Eur J Haemato1,2011,86 : 32-37.
6Storto G, Di GE, De Renzo A, et al. Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma[ J]. Br J Haematol,2010,151 : 195-197.
7Chan WK, Au WY, Wong CY, et al. Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas [ J ]. Clin Nucl Med, 2010, 35, 571-575.
